Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study”

Khalaf Kridin

doi:10.1016/j.jaad.2018.06.043

Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study”

Khalaf Kridin

School of Public Health

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e111-e112
Journal	Journal of the American Academy of Dermatology
Volume	79
Issue number	6
DOIs	https://doi.org/10.1016/j.jaad.2018.06.043
State	Published - Dec 2018

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaad.2018.06.043

Cite this

@article{8a40fe05de1c4926b1b41336547859f6,

title = "Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study”",

author = "Khalaf Kridin",

year = "2018",

month = dec,

doi = "10.1016/j.jaad.2018.06.043",

language = "English",

volume = "79",

pages = "e111--e112",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid

T2 - A Finnish nationwide case control study”

AU - Kridin, Khalaf

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85056334930&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.06.043

DO - 10.1016/j.jaad.2018.06.043

M3 - Letter

C2 - 30420009

AN - SCOPUS:85056334930

SN - 0190-9622

VL - 79

SP - e111-e112

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -

Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study”

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this